A Phase 2 Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200

Conditions:   Methamphetamine-dependence;   Methamphetamine Abuse Interventions:   Drug: IXT-m200;   Other: Placebo Sponsors:   InterveXion Therapeutics, LLC;   National Institute on Drug Abuse (NIDA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials